<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although risk factors for periprosthetic <z:e sem="disease" ids="C0860281" disease_type="Disease or Syndrome" abbrv="">joint infection</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e>) and mortality after total hip arthroplasty (THA) have been identified, interactions between specific patient risk factors are poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, it is difficult for surgeons to counsel patients on their individual risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> or mortality after THA </plain></SENT>
<SENT sid="2" pm="."><plain>QUESTIONS/PURPOSES: We evaluated the interaction between patient clinical and demographic factors on the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> and mortality after THA and developed an electronic risk calculator for estimating the patient-specific risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> and mortality in Medicare patients with THA </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We used the Medicare 5% sample claims database to calculate the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> within 2 years and mortality within 90 days after THA in 53,252 Medicare patients with primary THAs between 1998 and 2009 </plain></SENT>
<SENT sid="4" pm="."><plain>Logistic regression using 29 comorbid conditions, age, sex, race, and socioeconomic status were used as inputs to develop an electronic risk calculator to estimate patient-specific risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> and mortality after THA </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The overall 2-year risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> and 90-day risk of mortality after primary THA were 2.07% and 1.30%, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>White women aged 70 to 74 years with <z:e sem="disease" ids="C0085762" disease_type="Mental or Behavioral Dysfunction" abbrv="aca">alcohol abuse</z:e>, <z:hpo ids='HP_0000716'>depression</z:hpo>, electrolyte disorder, <z:hpo ids='HP_0004398'>peptic ulcer</z:hpo> disease, <z:hpo ids='HP_0000010'>urinary tract infection</z:hpo>, rheumatologic disease, preoperative <z:hpo ids='HP_0001903'>anemia</z:hpo>, cardiopulmonary (<z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo>, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pulmonary disease</z:e>) comorbidities, and <z:hpo ids='HP_0004950'>peripheral vascular disease</z:hpo> were at highest risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>White women aged 65 to 69 years with electrolyte disorder, <z:hpo ids='HP_0002301'>hemiplegia</z:hpo>/<z:hpo ids='HP_0010550'>paraplegia</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo>, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic tumor</z:e>, preoperative <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:hpo ids='HP_0003256'>coagulopathy</z:hpo>, cardiopulmonary (<z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pulmonary disease</z:e>) and psychiatric (<z:e sem="disease" ids="C0033975" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychoses</z:e>, <z:hpo ids='HP_0000716'>depression</z:hpo>) comorbidities, <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, and <z:hpo ids='HP_0004950'>peripheral vascular disease</z:hpo> were at highest risk for mortality </plain></SENT>
<SENT sid="8" pm="."><plain>An electronic risk calculator was developed to estimate the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> and mortality in Medicare patients with THA </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This electronic risk calculator can be used to counsel Medicare patients regarding their patient-specific risks of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PJI</z:e> and mortality after THA </plain></SENT>
<SENT sid="10" pm="."><plain>LEVEL OF EVIDENCE: Level II, prognostic study </plain></SENT>
<SENT sid="11" pm="."><plain>See the Instructions for Authors for a complete description of levels of evidence </plain></SENT>
</text></document>